CBG

CBG in Canada | Golden Boy Express

Welcome to Golden Boy Express, your premier source for CBG in Canada. Discover our curated selection of cannabigerol products, offering novel wellness benefits like anti‑inflammatory, neuroprotective, and anxiolytic effects—non‑psychoactive and expertly sourced.

What Is CBG?

Cannabigerol Explained

CBG (cannabigerol) is a non-intoxicating cannabinoid known as the "mother of all cannabinoids," because its precursor (CBGA) gives rise to THC, CBD, CBC, and other cannabinoids.

How It Works

While CBG does not induce a “high,” it interacts with cannabinoid (CB1/CB2), adrenergic, and serotonin receptors to positively influence pain, mood, appetite, and inflammation.

Potential Health Benefits of CBG

Anti‑Inflammatory & Pain Relief

Preclinical studies show CBG can reduce inflammation and alleviate pain via CB1/CB2 activation and antioxidant mechanisms.

Anxiety & Neuroprotection

Human trials found that 20 mg of CBG significantly reduced stress and anxiety within an hour, without intoxication; CBG may also offer neuroprotective support.

Skin Health & Antibacterial Action

CBG has been shown to exhibit anti-oxidant, anti-inflammatory, and antibacterial effects, benefiting skin conditions like acne or eczema.

Digestive & Neuromodulatory Support

Animal research indicates CBG helps with gut inflammation (e.g., colitis) and may modulate neurodegenerative processes, although further human trials are needed.

Why Choose CBG at Golden Boy Express

• High-Quality, Lab-Tested: All products undergo rigorous third-party testing for potency, purity, and THC compliance.
• Multiple Formats: Oils, softgels, gummies, and creams designed for targeted wellness needs.
• Non-Psychoactive & Safe: CBG won’t produce intoxication and is gently tolerated at low doses (e.g., 5–20 mg).

Choosing the Right CBG Product

Form & Delivery

• Oil/Tinctures: Ideal for fast absorption—sublingually or added to drinks.
• Edibles: Convenient with consistent dosing.
• Topicals: Great for localized pain or skin concerns.

Dosing & Onset

Start low (around 5 mg) and go slow—scaling to 20 mg for inflammation or mental wellness based on response.

Full-Spectrum vs. Isolate

Full-spectrum CBG may offer added benefits through the entourage effect; isolates are THC-free.

Frequently Asked Questions (FAQs)

Q: Is CBG legal in Canada?
A: Yes. Hemp-derived CBG with ≤ 0.3% THC is legal and available nationwide.

Q: Will CBG get me high?
A: No. CBG is non-intoxicating and does not produce a high, unlike THC.

Q: How long until I feel CBG's effects?
A: Effects can begin within 15–45 minutes for oils, 30–90 minutes for edibles, and 10–20 minutes for topicals.

Q: Any side effects?
A: Generally well-tolerated. Some people report mild dry mouth or drowsiness.

Explore Our CBG Collection Today

At Golden Boy Express, we're dedicated to bringing you top-tier CBG products in Canada for wellness, comfort, and peace of mind. Discover lab-tested tinctures, creams, topicals, and edibles—backed by science and crafted with care.

References

Ammar, M., Cascio, M. G., & Battista, N. (2023). The Therapeutic Potential of Cannabigerol: An Overview. Molecules, 28(3), 1342. https://doi.org/10.3390/molecules28031342

Brierley, D. I., Samuels, J., Duncan, M., Whalley, B. J., & Williams, C. M. (2017). Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats. Psychopharmacology, 234, 1897–1907. https://doi.org/10.1007/s00213-017-4593-8

Nachnani, R., Raup-Konsavage, W. M., & Vrana, K. E. (2021). The pharmacological case for cannabigerol. Journal of Pharmacology and Experimental Therapeutics, 376(2), 204–212. https://doi.org/10.1124/jpet.120.000207

Vigil, J. M., Stith, S. S., Adams, I. M., & Reeve, A. P. (2022). Effects of Cannabigerol (CBG) on anxiety and stress in adults: Results from a large online survey. Journal of Cannabis Research, 4(1), 5. https://doi.org/10.1186/s42238-021-00081-6

Deiana, S. (2017). Potential medical uses of cannabigerol: a brief overview. In M. A. ElSohly (Ed.), Marijuana and the Cannabinoids (pp. 163–173). Springer. https://doi.org/10.1007/978-1-59259-947-9_10

Rock, E. M., Parker, L. A., Limebeer, C. L., & Mechoulam, R. (2011). Cannabidiol and Cannabigerol are cannabinoids that inhibit nausea and vomiting in pre-clinical models. British Journal of Pharmacology, 163(7), 1411–1422. https://doi.org/10.1111/j.1476-5381.2011.01238.x

Appendino, G., Gibbons, S., Giana, A., Pagani, A., Grassi, G., Stavri, M., ... & Ballero, M. (2008). Antibacterial cannabinoids from Cannabis sativa: A structure− activity study. Journal of Natural Products, 71(8), 1427–1430. https://doi.org/10.1021/np8002673

Howlett, A. C., & Abood, M. E. (2017). CB1 and CB2 receptor pharmacology. In Cannabinoid Pharmacology (pp. 53–72). Springer. https://doi.org/10.1007/978-3-319-45541-9_3